Statins Market 2022
Statins are special class of drugs that helps in lowering of blood cholesterol level in the body. This is prescribed to lower down the low density lipoprotein (LDL) cholesterol in the body and thus reduce mortality in high risk patients. Demand for statins is long driven by increasing healthcare awareness among common masses. In U.S., over 500,000 people suffers heart attack every year.
Though cholesterol level is easy to maintain provided one follow healthy diet, sedentary lifestyle has been a major challenge for over last several years. As such, over quarter of the Americans in U.S. take statins to lower down the cholesterol level. Over the past few years, statins market has proved to be a lucrative and profitable market, especially for players that are focused on it. Consumption of statins is quite high among geriatrics population.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3038
Rise in prevalence of cholesterol owing to changing lifestyle has led to increased demand for statins worldwide. As per the WHO, Europe followed by North America has witnessed highest elevated total cholesterol level worldwide. There has been a significant rise in patients with obesity, cardiovascular diseases and diabetes which in turn is expected to drive the demand for statins worldwide.
In North America, over 70% American adults are suffering from LDL cholesterol. As such, demand for effective treatment of LDL cholesterol has led to increased demand of statins globally. Furthermore, increase in healthcare expenditure in emerging regions along with technological advancement, modern healthcare amenities, and various cholesterol related healthcare campaign is expected to boost overall demand for stains worldwide.
Though the market is poised to grow at a significant rate, increasing preference for alternative medicines in emerging regions is proving a major challenge for overall growth of the stains market. Degrading socioeconomic conditions is another key restraint for this market.
Request for Table of Content@ https://www.persistencemarketresearch.com/toc/3038
Statins Market is broadly classified on the basis of the following segments –
|Statins Market by Drug Class
|Statins Market by Therapeutic Treatment
|Statins Market by End User
The statins market is expected to witness healthy CAGR during the forecast period. With rapid technological advancement and innovation, statins market is expected to grow globally. North America and Europe are the largest market for statins while Asia Pacific is expected to be the fastest growing market during the forecast period.
The statins market is expected to register a significant CAGR during the forecast period.The statins market is led by North America followed by Europe and Asia Pacific. North America statins market is expected to expand slowly when compared to Asia Pacific.
Latin America and MEA are expected to witness moderate growth during the forecast period. Increase in incidence rate of obesity and cardiovascular related disorders in emerging regions along with changes in healthcare regulatory regimes in some of these regions is expected to boost overall demand for statins in developing regions.
Many companies are focusing on strengthening their distribution networks in Asia Pacific to expand their market presence as well as increase their profit pools over the next few years.
Some of the key market players for statins market are AstraZeneca plc, Pfizer Inc., GlaxoSmithKline plc, Novartis International AG, Merck & Co., Inc., Biocon, Concord Biotech, and Aurobindo Pharma Ltd.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/3038
Key Questions Answered in This Report.
- What will the Market growth rate in Future?
- What are the key factors driving the global Market?
- Who are the key manufacturers in Market space?
- What are the opportunities and threats faced by the vendors in the global industry?
- What are sales, revenue, and price analysis by regions of industry?
About Us: Persistence Market Research
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]